
A novel mutation in a mouse gene, which could provide new insights into the genetic roots of alcoholism in humans has been pinpointed by scientists.
The mutation, which the researchers at the Ernest Gallo Clinic and Research Center and the University of California, San Francisco, have named Lightweight, is in the mouse version of a gene called unc-79.
Advertisement
Previous studies in worms and flies have shown that unc-79 is associated with altered sensitivity to a variety of anesthetics, including alcohol.
The mutant mice are more sensitive to alcohol than their normal, wild-type littermates, and voluntarily consume more alcohol than normal mice when offered the choice between alcohol and water.
Lead author Dr. David Speca says that the name Lightweight refers to the observation that when unc-79 mutant mice were injected with high doses of alcohol "they were knocked out for far longer than normal mice."
The function of unc-79 is not well understood, says Speca, but he notes that experiments by other researchers suggest it may interact with a particular neuron channel (a complex of proteins essential to nerve cell function), named NALCN, to influence neuronal responses to alcohol.
Although the study did not demonstrate an interaction with this channel in Lightweight mice, Speca said that follow-up experiments in the roundworm Caenorhabditis elegans showed that the NALCN channel influences responses to alcohol, "suggesting that this response may be conserved from worms to mice to humans."
Studies of human twins have suggested that there is a genetic component to alcoholism, but, according to Speca, it is likely that there are multiple genes that contribute to the disease, each with its own effect, making it difficult to identify the causative factors.
The question now, he says, is whether unc-79 and the NALCN neuron channel turn out to be associated with altered responses to alcohol in humans.
"Nobody has ever studied these genes in humans before. There's a chance that it's part of a new and relatively unexplored biochemical pathway that may tell us something about human susceptibility to alcoholism," notes Speca.
The study is published in the open-access journal PLoS Genetics.
Source: ANI
Advertisement
Lead author Dr. David Speca says that the name Lightweight refers to the observation that when unc-79 mutant mice were injected with high doses of alcohol "they were knocked out for far longer than normal mice."
The function of unc-79 is not well understood, says Speca, but he notes that experiments by other researchers suggest it may interact with a particular neuron channel (a complex of proteins essential to nerve cell function), named NALCN, to influence neuronal responses to alcohol.
Although the study did not demonstrate an interaction with this channel in Lightweight mice, Speca said that follow-up experiments in the roundworm Caenorhabditis elegans showed that the NALCN channel influences responses to alcohol, "suggesting that this response may be conserved from worms to mice to humans."
Studies of human twins have suggested that there is a genetic component to alcoholism, but, according to Speca, it is likely that there are multiple genes that contribute to the disease, each with its own effect, making it difficult to identify the causative factors.
The question now, he says, is whether unc-79 and the NALCN neuron channel turn out to be associated with altered responses to alcohol in humans.
"Nobody has ever studied these genes in humans before. There's a chance that it's part of a new and relatively unexplored biochemical pathway that may tell us something about human susceptibility to alcoholism," notes Speca.
The study is published in the open-access journal PLoS Genetics.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Genetics & Stem Cells News

Relapsing-remitting multiple sclerosis has been successfully treated using autologous hematopoietic stem cell therapy.

Innovative discoveries in male hair loss research uncover uncommon genetic variants tied to it.

Researchers achieved a significant milestone in uncovering the genetic basis of dilated cardiomyopathy in Dobermanns.

Groundbreaking gene therapy for genetic beta thalassemia is now accessible as a treatment to a patient post-FDA approval.

Thymic stem cells actively participate in their environment by generating extracellular matrix proteins, essentially forming their own support system.